Glyco4Clinics Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Glyco4Clinics General Information


Operator of a biotechnology company intended to develop new biomarkers applied to diagnosis, as well as the creation of new therapeutic agents tested and validated in clinical trials. The company investigate changes in the protein glycosylation profile in the context of human diseases and develop new biomarkers for diagnosis and prognosis, enabling healthcare companies in creating new therapeutic agents and devices.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Rua Alfredo Allen, 455-461
  • Porto, 4200-135
  • Portugal
+351 966 000 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glyco4Clinics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 07-Mar-2021 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Glyco4Clinics’s complete valuation and funding history, request access »